340binformed.org

Your Free Source for 340B News and Commentary

  • About us
  • Advertise
  • Contact
  • 340B Health

Genentech Overcharges Underscores Need For HRSA Action

 

Genentech, the biotech giant leading the charge for drug manufacturer audits of 340B safety net health care providers, admitted yesterday that it overcharged those caregivers for a big chunk of its entire product line from the middle of 2008 through the middle of 2011. The California-based company's Swiss owner, F. Hoffmann-La Roche AG, racked up 9.54 billion Swiss francs in … [Read more...]

Genentech Issuing Refunds for 340B Overcharges

Notice covers 19 products sold between 3Q 2008 and 2Q 2011 

(UPDATED September 3, 2013 with comment from Genentech) August 29, 2013—The biopharmaceutical giant Genentech will be providing refunds to 340B covered entities on 19 of its products sold from the third quarter of 2008 through the second quarter of 2011 due to a recalculation of its Medicaid average manufacturer prices and best prices, according to a notice by the company … [Read more...]

HHS Report Urges Huge Reduction in Critical Access Hospitals

Roughly 65% of CAHs receive 340B drug discounts 

August 19, 2013—A Department of Health and Human Services (HHS) Office of Inspector General (OIG) report recommending a nearly two-thirds cut in the number of critical access hospitals (CAHs) would "kill rural health care," the National Rural Health Association (NRHA) says. … [Read more...]

340B Hospital Recertification to Begin on Aug. 19

Rural and cancer hospitals will have to declare how they will buy orphan drugs 

August 14, 2013—Rural and cancer hospitals will get their first hands-on experience complying with the new 340B orphan drug exclusion regulation beginning next Monday, the start of the four-week period during which they and all other 340B hospitals must recertify their eligibility for the drug discount program. … [Read more...]

113 Members of Congress Sign Letters Supporting 340B

Savings enable hospitals to expand services, serve more patients, and offset losses, they say 

August 9, 2013—More than 100 members of Congress (84 representatives and 29 senators) have signed letters to leaders of their respective chambers expressing their "bipartisan support" for the 340B drug discount program. … [Read more...]

Senator Hatch Criticizes 340B Orphan Drug Exclusion Rule

HRSA interpreted law incorrectly, he tells Administrator Wakefield in letter 

August 2, 2013—Sen. Orrin Hatch (R-Utah) has sent a letter to HRSA Administrator Mary Wakefield saying the agency's 340B orphan drug exclusion final regulation is "incorrectly interpreting the law" and diminishes incentives for orphan drug development. … [Read more...]

Senator Grassley Questions Walgreens About Its Participation in 340B

Seeks information about its role as a contract pharmacy 

August 1, 2013—Sen. Charles Grassley (R-Iowa) sent a letter yesterday to Walgreens requesting detailed information about its participation in the 340B program as a contract pharmacy, including its financial arrangements with covered entities. … [Read more...]

« Previous Page
Next Page »

LATEST ARTICLES DELIVERED

Get new article alerts via email.

This field is required.

Check your inbox or spam folder now to confirm your subscription.

FOLLOW | SHARE | LIKE

  • Facebook
  • LinkedIn
  • Twitter
  • YouTube

340B Health Twitter

Twitter feed is not available at the moment.

RSS feed: 340B Employed 340B Employed

  • 340B Program Compliance Analyst Certified | UNC Health November 17, 2026
  • 340B Program Compliance Analyst Certified | UNC Health November 17, 2026
  • 340B Program Specialist | Vail Health November 17, 2026
  • Pharmacy Manager, 340B Program | Tufts Medical Center November 11, 2026
  • 340B Program Pharmacy Manager | Allies for Health + Wellbeing November 10, 2026

Copyright © 2026 · 340B Health